vs

Side-by-side financial comparison of DARLING INGREDIENTS INC. (DAR) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.

DARLING INGREDIENTS INC. is the larger business by last-quarter revenue ($1.6B vs $1.1B, roughly 1.4× PERRIGO Co plc). DARLING INGREDIENTS INC. runs the higher net margin — 1.2% vs -127.8%, a 129.0% gap on every dollar of revenue. On growth, DARLING INGREDIENTS INC. posted the faster year-over-year revenue change (10.0% vs -2.5%). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -1.6%).

Darling Ingredients Inc. is a global sustainable natural ingredients maker that converts edible and inedible organic byproducts into high-value products: food-grade nutritional ingredients, animal feed additives, pharmaceutical raw materials and biofuel components, serving food, agriculture, pharma and renewable energy markets across North America, Europe and Asia-Pacific.

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...

DAR vs PRGO — Head-to-Head

Bigger by revenue
DAR
DAR
1.4× larger
DAR
$1.6B
$1.1B
PRGO
Growing faster (revenue YoY)
DAR
DAR
+12.5% gap
DAR
10.0%
-2.5%
PRGO
Higher net margin
DAR
DAR
129.0% more per $
DAR
1.2%
-127.8%
PRGO
Faster 2-yr revenue CAGR
PRGO
PRGO
Annualised
PRGO
1.3%
-1.6%
DAR

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DAR
DAR
PRGO
PRGO
Revenue
$1.6B
$1.1B
Net Profit
$19.4M
$-1.4B
Gross Margin
24.7%
32.6%
Operating Margin
4.6%
-116.0%
Net Margin
1.2%
-127.8%
Revenue YoY
10.0%
-2.5%
Net Profit YoY
14.2%
-3093.9%
EPS (diluted)
$0.12
$-10.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DAR
DAR
PRGO
PRGO
Q4 25
$1.1B
Q3 25
$1.6B
$1.0B
Q2 25
$1.5B
$1.1B
Q1 25
$1.4B
$1.0B
Q4 24
$1.4B
$1.1B
Q3 24
$1.4B
$1.1B
Q2 24
$1.5B
$1.1B
Q1 24
$1.4B
$1.1B
Net Profit
DAR
DAR
PRGO
PRGO
Q4 25
$-1.4B
Q3 25
$19.4M
$7.5M
Q2 25
$12.7M
$-8.4M
Q1 25
$-26.2M
$-6.4M
Q4 24
$101.9M
$-44.4M
Q3 24
$16.9M
$-21.0M
Q2 24
$78.9M
$-108.4M
Q1 24
$81.2M
$2.0M
Gross Margin
DAR
DAR
PRGO
PRGO
Q4 25
32.6%
Q3 25
24.7%
36.1%
Q2 25
23.3%
34.4%
Q1 25
22.6%
37.6%
Q4 24
23.5%
33.9%
Q3 24
22.1%
37.2%
Q2 24
22.5%
37.0%
Q1 24
21.4%
33.1%
Operating Margin
DAR
DAR
PRGO
PRGO
Q4 25
-116.0%
Q3 25
4.6%
7.0%
Q2 25
5.1%
4.3%
Q1 25
2.1%
4.5%
Q4 24
8.6%
10.0%
Q3 24
4.2%
7.4%
Q2 24
10.2%
-2.5%
Q1 24
9.7%
-5.1%
Net Margin
DAR
DAR
PRGO
PRGO
Q4 25
-127.8%
Q3 25
1.2%
0.7%
Q2 25
0.9%
-0.8%
Q1 25
-1.9%
-0.6%
Q4 24
7.2%
-3.9%
Q3 24
1.2%
-1.9%
Q2 24
5.4%
-10.2%
Q1 24
5.7%
0.2%
EPS (diluted)
DAR
DAR
PRGO
PRGO
Q4 25
$-10.23
Q3 25
$0.12
$0.05
Q2 25
$0.08
$-0.06
Q1 25
$-0.16
$-0.05
Q4 24
$0.63
$-0.32
Q3 24
$0.11
$-0.15
Q2 24
$0.49
$-0.79
Q1 24
$0.50
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DAR
DAR
PRGO
PRGO
Cash + ST InvestmentsLiquidity on hand
$91.5M
Total DebtLower is stronger
$4.0B
Stockholders' EquityBook value
$4.7B
$2.9B
Total Assets
$10.5B
$8.5B
Debt / EquityLower = less leverage
0.86×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DAR
DAR
PRGO
PRGO
Q4 25
Q3 25
$91.5M
$432.1M
Q2 25
$94.6M
$454.2M
Q1 25
$81.5M
$409.9M
Q4 24
$76.0M
$558.8M
Q3 24
$114.8M
$1.5B
Q2 24
$121.6M
$542.8M
Q1 24
$145.5M
$658.5M
Total Debt
DAR
DAR
PRGO
PRGO
Q4 25
Q3 25
$4.0B
Q2 25
$3.9B
Q1 25
$3.8B
Q4 24
$3.9B
Q3 24
$4.1B
Q2 24
$4.3B
Q1 24
$4.4B
Stockholders' Equity
DAR
DAR
PRGO
PRGO
Q4 25
$2.9B
Q3 25
$4.7B
$4.4B
Q2 25
$4.6B
$4.5B
Q1 25
$4.4B
$4.4B
Q4 24
$4.4B
$4.3B
Q3 24
$4.6B
$4.6B
Q2 24
$4.5B
$4.5B
Q1 24
$4.6B
$4.7B
Total Assets
DAR
DAR
PRGO
PRGO
Q4 25
$8.5B
Q3 25
$10.5B
$10.1B
Q2 25
$10.3B
$10.1B
Q1 25
$10.0B
$9.8B
Q4 24
$10.1B
$9.6B
Q3 24
$10.6B
$11.2B
Q2 24
$10.6B
$10.4B
Q1 24
$10.9B
$10.6B
Debt / Equity
DAR
DAR
PRGO
PRGO
Q4 25
Q3 25
0.86×
Q2 25
0.85×
Q1 25
0.86×
Q4 24
0.89×
Q3 24
0.91×
Q2 24
0.97×
Q1 24
0.95×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DAR
DAR
PRGO
PRGO
Operating Cash FlowLast quarter
$224.3M
$175.4M
Free Cash FlowOCF − Capex
$148.6M
FCF MarginFCF / Revenue
13.4%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
11.59×
TTM Free Cash FlowTrailing 4 quarters
$145.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DAR
DAR
PRGO
PRGO
Q4 25
$175.4M
Q3 25
$224.3M
$51.7M
Q2 25
$145.8M
$75.9M
Q1 25
$249.0M
$-64.5M
Q4 24
$154.4M
$312.6M
Q3 24
$274.5M
$42.2M
Q2 24
$146.5M
$9.5M
Q1 24
$263.9M
$-1.4M
Free Cash Flow
DAR
DAR
PRGO
PRGO
Q4 25
$148.6M
Q3 25
$29.8M
Q2 25
$56.7M
Q1 25
$-90.0M
Q4 24
$274.9M
Q3 24
$15.1M
Q2 24
$-18.9M
Q1 24
$-26.5M
FCF Margin
DAR
DAR
PRGO
PRGO
Q4 25
13.4%
Q3 25
2.9%
Q2 25
5.4%
Q1 25
-8.6%
Q4 24
24.2%
Q3 24
1.4%
Q2 24
-1.8%
Q1 24
-2.4%
Capex Intensity
DAR
DAR
PRGO
PRGO
Q4 25
2.4%
Q3 25
2.1%
Q2 25
1.8%
Q1 25
2.4%
Q4 24
3.3%
Q3 24
2.5%
Q2 24
2.7%
Q1 24
2.3%
Cash Conversion
DAR
DAR
PRGO
PRGO
Q4 25
Q3 25
11.59×
6.89×
Q2 25
11.52×
Q1 25
Q4 24
1.52×
Q3 24
16.19×
Q2 24
1.86×
Q1 24
3.25×
-0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DAR
DAR

Fats$428.4M27%
Food Ingredients$380.6M24%
Diamond Green Diesel Holdings Llc Joint Venture$342.1M22%
Fuel Ingredients$154.3M10%
Used Cooking Oil$125.9M8%
Other Rendering$76.9M5%
Bakery$46.9M3%
Other Products And Services$12.2M1%

PRGO
PRGO

Consumer Self Care Americas$697.0M63%
Digestive Health$123.9M11%
Nutrition$108.3M10%
Healthy Lifestyle$94.8M9%
Pain And Sleep Aids$87.1M8%

Related Comparisons